Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Computer Modelling Group Announces Third Quarter Results and Quarterly Dividend
-
RAMON: The Most Bullish Meme Launch of 2025 Is Coming to Solana
-
RAMON: The Most Bullish Meme Launch of 2025 Is Coming to Solana
-
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
-
Topicus.com Inc. Announces Release Date for Fourth Quarter Results
-
Constellation Software Inc. Announces Release Date for Fourth Quarter Results
-
Critical One Announces Issuance of Shares in Connection with Howells Lake Acquisition, Debt Settlement and Finders Fees
-
The Meet Kevin Pricing Power ETF (PP) to Close
-
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
Ingersoll Rand Sets Industry Standards for Sustainable Progress
-
Outbrain Announces Closing of New Senior Secured Notes Due 2030
-
POET’s Chairman & CEO Provides Business Update
-
TEGNA Announces Quarterly Dividend
-
ARMOUR Residential REIT, Inc. Announces March 2025 Dividend Rate per Common Share
-
Artisan Partners Asset Management Inc. Reports January 2025 Assets Under Management
-
Evolution Petroleum Reports Fiscal Second Quarter 2025 Results and Declares Quarterly Cash Dividend for Fiscal Third Quarter
-
California Water Service Partners with Walmart to Expand Payment Options for Cash- and Debit Card-Paying Customers
-
Precision Optics Schedules Second Quarter of Fiscal Year 2025 Conference Call for February 13, 2025
-
Highwoods Announces Availability of Fourth Quarter and Full Year 2024 Results
-
ARMOUR Residential REIT, Inc. Fourth Quarter 2024 Webcast Scheduled for February 13, 2025
-
Kite Realty Group Reports Fourth Quarter and Full Year 2024 Operating Results and Provides 2025 Guidance
-
Forafric Adopts New Balance Sheet Strengthening Strategy
-
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Freshworks Reports Fourth Quarter and Full Year 2024 Results
-
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
-
Angi Inc. Earnings Release and Letter to Shareholders Available on Company’s Website
-
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
-
CNB Financial Corporation Announces Quarterly Dividend For Common Stock
-
Tim Pool Joins Rumble & Brings His Exclusive Timcast show to Rumble Premium
-
BlackLine Announces Fourth Quarter and Full Year 2024 Financial Results
-
Anterix Inc. Reports Third Quarter Fiscal Year 2025 Results
-
Oxbridge / SurancePlus to Participate in Digital Assets 2025 Virtual Conference Presented by Maxim Group LLC on February 12th
-
Tim Pool Joins Rumble & Brings His Exclusive Timcast show to Rumble Premium
-
Getty Realty Corp. Announces Regular Quarterly Cash Dividend
-
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 31, 2025
-
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
-
Regeneron Announces Investor Conference Presentations
-
Drop. Deliver. Dominate: ParaZero’s AirDrop System Nails Defense Demonstration
-
Globus Maritime Announces Agreement to Sell the River Globe, a Supramax Vessel
-
Cricut to Announce Fourth Quarter 2024 Financial Results on March 4, 2025
-
Grocery Outlet Holding Corp. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call Date
-
Navitas Semiconductor to Report Q4 and Full Year 2024 Financial Results on Monday, February 24th, 2025 and Participate in Upcoming Investor Events
-
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
-
DoubleDown Interactive Reports Fourth Quarter and Full Year 2024 Financial Results
-
Safe Bulkers, Inc. Sets Date for the Fourth Quarter 2024 Results, Conference Call, and Webcast
-
Monarch Casino & Resort Reports Record 2024 Fourth Quarter Financial Results
-
Avis Budget Group Reports Fourth Quarter and Full Year Results
-
CSX Chief Executive Officer and Chief Financial Officer to Address Barclays Industrial Select Conference
-
Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01, a Pivotal Phase 2/3 Clinical Trial of Ficerafusp Alfa in 1L Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

